Walleye Capital LLC Has $3.46 Million Holdings in Surgery Partners, Inc. $SGRY

Key Points

• Walleye Capital LLC reduced its stake in Surgery Partners, Inc. by 64.4%, selling 263,592 shares and now holds 145,508 shares worth approximately $3.46 million as of the first quarter.
• Janus Henderson Group PLC boosted its holdings in Surgery Partners by 110.2% in the same quarter, owning over 11.5 million shares valued at about $244.6 million.
• The company reported a quarterly revenue of $826.20 million, surpassing analysts' estimates, while it has a consensus rating of "Moderate Buy" with an average target price of $33.00.

Walleye Capital LLC lessened its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 64.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 145,508 shares of the company's stock after selling 263,592 shares during the quarter. Walleye Capital LLC owned 0.11% of Surgery Partners worth $3,456,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in SGRY. Janus Henderson Group PLC grew its position in Surgery Partners by 110.2% in the fourth quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company's stock worth $244,616,000 after acquiring an additional 6,057,477 shares in the last quarter. Wellington Management Group LLP boosted its position in Surgery Partners by 19.7% during the first quarter. Wellington Management Group LLP now owns 7,091,756 shares of the company's stock worth $168,429,000 after purchasing an additional 1,165,667 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Surgery Partners by 18.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after buying an additional 563,812 shares during the period. King Street Capital Management L.P. boosted its holdings in shares of Surgery Partners by 93.1% during the 4th quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company's stock worth $59,276,000 after buying an additional 1,350,000 shares during the period. Finally, Point72 Asset Management L.P. grew its stake in Surgery Partners by 224.7% in the 4th quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company's stock valued at $36,975,000 after buying an additional 1,208,639 shares during the last quarter.

Insider Activity at Surgery Partners

In other news, Director Teresa Deluca sold 20,018 shares of Surgery Partners stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $22.74, for a total transaction of $455,209.32. Following the sale, the director directly owned 45,173 shares in the company, valued at approximately $1,027,234.02. The trade was a 30.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.70% of the company's stock.

Surgery Partners Stock Performance

Shares of SGRY traded down $0.11 on Tuesday, reaching $22.58. 1,157,421 shares of the stock traded hands, compared to its average volume of 1,487,585. The firm has a market cap of $2.89 billion, a price-to-earnings ratio of -15.79 and a beta of 1.76. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. Surgery Partners, Inc. has a 12 month low of $18.87 and a 12 month high of $33.90. The stock's 50-day moving average price is $22.44 and its 200-day moving average price is $22.75.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The firm had revenue of $826.20 million during the quarter, compared to analysts' expectations of $816.96 million. During the same period last year, the business earned $0.21 earnings per share. Surgery Partners's quarterly revenue was up 8.4% compared to the same quarter last year. Equities analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently weighed in on SGRY shares. Bank of America started coverage on Surgery Partners in a research note on Monday, July 28th. They set a "buy" rating and a $28.00 target price for the company. Barclays reduced their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a report on Tuesday, May 27th. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.